Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registryDiane E. Brown, Amita Bansal, Anne Dennos et al.|Pediatric Rheumatology|2025Cited by 1